A qualitative exploration of pharmacists and customers barriers and facilitators to community pharmacy PrEP delivery using the COM-B model of behaviour change.
Harrison, C. R.; Family, H.; Kesten, J.; Denford, S.; Scott, J.; Sabin, C.; Copping, J.; Harryman, L.; Cochrane, S.; Saunders, J.; Hamilton-Shaw, R.; Horwood, J.
Show abstract
ObjectivesExpanding delivery of oral Pre-exposure Prophylaxis (PrEP) to community pharmacies could improve access, aligning well with government goals for England to eliminate new HIV acquisitions by 2030. Using the Capability, Opportunity, Motivation, Behaviour (COM-B) model for behaviour change, the aim of this research was to explore the barriers and facilitators of community pharmacy PrEP delivery, for pharmacists and community members. MethodsCommunity members at elevated risk of acquiring HIV and community pharmacists were recruited to participate in semi-structured interviews. Interviews were recorded, transcribed, and thematically analysed within the framework of the COM-B model. Results17 interviews with pharmacists (pharmacy owners n=7; employed pharmacists n=6; locums n=4) and 24 with community members (Black African women n=6; other women n=2; young adults aged 18-25 years n=6; transgender people n=6; female sex workers n=4) were carried out. Capability barriers included sub-optimal awareness and knowledge of PrEP, pharmacy facilities, and pharmacist roles in delivering public health services. Opportunity barriers included lack of staff capacity, privacy and pharmacy screening and monitoring facilities. Motivational barriers included a concern that increased access could increase sexually transmitted infections and involve a financial cost. Capability facilitators included awareness raising, HIV and PrEP training and education. Opportunity facilitators included PrEP appointments and the accessibility of pharmacies. Motivational facilitators included a preference for pharmacy delivery over other models (e.g., sexual health, GP), and a belief that it would be discrete and less stigmatising. ConclusionPharmacy PrEP delivery is acceptable but for it to be feasible, results point to the need for the development of a behaviour change intervention focusing on education, training and awareness raising, targeting pharmacists and community members to stimulate patient activation and de-stigmatise HIV. This intervention would need to be facilitated by system and environmental changes (e.g., commissioning service). Key messagesO_ST_ABSWhat is already known on this topicC_ST_ABSLocation, sigma of sexual health clinics and lack of PrEP awareness limits PrEP access for key groups among whom new HIV acquisitions remain high. Previous research and the UK government suggests PrEP provision via community pharmacies as a potential way of improving PrEP access and health equity. What this study addsThis is the first research study to explore the barriers to and facilitators of pharmacy PrEP delivery for pharmacists and community members in the UK. To increase capabilities and motivation, training and awareness raising is needed. To increase opportunities and motivation, environmental and system level changes are needed. How this study might affect research, practice or policyResults point to the acceptability of pharmacy PrEP delivery, but for it to be feasible behaviour change interventions supported by system and environmental changes are needed.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- HIV Pre-exposure Prophylaxis (PrEP) Practices in Florida, USA: Clinicians Perceptions of Initiation, Risk Identification, Barriers, and Facilitators 94%
- Perspectives of pharmacy employees on an inappropriate use of antimicrobials in Kathmandu, Nepal 94%
- A Descriptive Analysis of Calls to the NSW Teratogen Information Service regarding use of anti-infectives during pregnancy 93%
Similar papers in this journal
Similar papers in this journal
- Female Sex Worker Preferences for HIV Pre-Exposure Prophylaxis Delivery in Uganda: A Discrete Choice Experiment 95%
- Evaluating the implementation of weekly rifapentine-isoniazid (3HP) for tuberculosis prevention among people living with HIV in Uganda: A qualitative evaluation of the 3HP Options Trial 94%
- Drug Supply Management at First-level Public Health Facilities: Case of Pyay District, Myanmar 94%
Similar papers in this journal
- A community-engaged mHealth intervention to increase uptake of HIV Pre-Exposure Prophylaxis (PrEP) among gay, bisexual and other men who have sex with men in China: Study protocol for a pilot randomized controlled trial 93%
- A Rapid Realist Review of the Role of Community Pharmacy in the Public Health Response to COVID-19 93%
- Risks of use and non-use of antibiotics in primary care. Qualitative study of prescribers' views 92%
Similar papers in this journal
- Understanding Opportunities for Prescribing Pre-exposure Prophylaxis (PrEP) at Two Academic Medical Centers in a High Priority Jurisdiction for Ending the HIV Epidemic 94%
- “I had made the decision, and no one was going to stop me” —Facilitators of PrEP adherence during pregnancy and postpartum in Cape Town, South Africa 94%
- Maternal PrEP use in HIV-uninfected pregnant women in South Africa: Role of Stigma in PrEP initiation, retention and adherence 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.